Author:
Nguyen Danh V.,Qian Qi,You Amy S.,Kurum Esra,Rhee Connie M.,Senturk Damla
Abstract
Profiling analysis aims to evaluate health care providers, including hospitals, nursing homes, or dialysis facilities among others with respect to a patient outcome, such as 30-day unplanned hospital readmission or mortality. Fixed effects (FE) profiling models have been developed over the last decade, motivated by the overall need to (a) improve accurate identification or “flagging” of under-performing providers, (b) relax assumptions inherent in random effects (RE) profiling models, and (c) take into consideration the unique disease characteristics and care/treatment processes of end-stage kidney disease (ESKD) patients on dialysis. In this paper, we review the current state of FE methodologies and their rationale in the ESKD population and illustrate applications in four key areas: profiling dialysis facilities for (1) patient hospitalizations over time (longitudinally) using standardized dynamic readmission ratio (SDRR), (2) identification of dialysis facility characteristics (e.g., staffing level) that contribute to hospital readmission, and (3) adverse recurrent events using standardized event ratio (SER). Also, we examine the operating characteristics with a focus on FE profiling models. Throughout these areas of applications to the ESKD population, we identify challenges for future research in both methodology and clinical studies.
Subject
Health Information Management,Health Informatics,Health Professions (miscellaneous),Statistics and Probability
Reference76 articles.
1. United States Renal Data System. USRDS 2022Annual Data Report: Epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Available fromhttps://adr.usrds.org/2022.
2. United States Renal Data System. USRDS 2020 Annual Data Report: Epidemiology of Kidney Disease and in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. [cited 2020]: Available from https://adr.usrds.org/2020.
3. Kalantar-Zadeh K, Kovesdy CP, Streja E, Rhee MC, Soohoo M, Chen JLT, Molnar MZ, Gillen D, Nguyen DV, Norris KC, Sim JJ, Jacobsen SS Transition of care from pre-dialysis prelude to renal replacement therapy: the blueprints of emerging research in advanced chronic kidney disease. Nephrol Dial Transplant 2017; 32(suppl_2): ii91-ii98. https://doi.org/10.1093/ndt/gfw357
4. United States Renal Data System. USRDS 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States.National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
5. Soohoo M, Streja E, Obi Y, Rhee CM, Gillen DL, Sumida K, Nguyen DV, Kovesdy CP, Kalantar-Zadeh K. Predialysis kidney function and its rate of decline predict mortality and hospitalization after starting dialysis. Mayo Clinic Proceedings 2018; 93(8): 1074-1085. https://doi.org/10.1016/j.mayocp.2018.01.030